 PR Web (press release) | MS Patient Website to Provide Most Extensive On-Site Coverage at AAN PR Web (press release) “We're expecting updates of important trials of oral drugs such as Gilenya, Aubagio and BG-12, as well as the infusion drugs such as Tysabri, alemtuzumab and daclizumab. This information is vital to help people make informed decisions about their ... |
